FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

CareFusion 213 SEPP 2% Iodine Tincture Recall

SEPP 2% Iodine Tincture USP (47% v/v Ethyl Alcohol, 2% w/v Iodine, USP, Sodium Iodide U…

CareFusion 213, LLC · El Paso, TX

Risk level
Class II
Reported by FDA
Apr 3, 2013
Recall ID
D-225-2013
Check your lot numberHow we source this data

Summary

CareFusion 213 recalled SEPP 2% Iodine Tincture starting Mar 4, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-225-2013 on Apr 3, 2013. Reason: Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims. Status: Terminated.

Why it was recalled

Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.

Product description

SEPP 2% Iodine Tincture USP (47% v/v Ethyl Alcohol, 2% w/v Iodine, USP, Sodium Iodide USP, & Purified Water USP), packaged in a) 200-count applicators (Net 0.67 mL each) per carton, Cat. No 260261, NDC 54365-161-01, CareFusion, Leawood, KS 66211; b) 3000-count applicators (Net 0.67 mL each) per case, Cat. No 260431, NDC 54365-151-01, CareFusion, Leawood, KS 66211; and c) 3000-count applicators (Net 0.67 mL each) per case, Reorder TA6200, Manufactured for: Tri-State Hospital Supply Corporation, Howell, MI 48843.

Lot numbers, UPCs & expiration codes

a) All lots with expiry between 02/12 to 10/15; b) All lots with expiry between 09/11 to 12/13; and c) All lots with expiry between 12/11 to 12/11.

Where it was sold

Nationwide, Puerto Rico, Virgin Islands, Malaysia, and United Kingdom

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-225-2013
Classification
Class II
Status
Terminated
Recall initiated
Mar 4, 2013
FDA report date
Apr 3, 2013
Quantity
3,032,000 applicators
Recall type
Voluntary: Firm initiated
Recalling firm
CareFusion 213, LLC

Original FDA data

Every field from FDA enforcement report D-225-2013, exactly as published.

Show all FDA fields
City
El Paso
State
TX
Status
Terminated
Country
United States
Event ID
64583
Address
1550 Northwestern Drive
Code information
a) All lots with expiry between 02/12 to 10/15; b) All lots with expiry between 09/11 to 12/13; and c) All lots with expiry between 12/11 to 12/11.
Postal code
79912-8000
Report date
Apr 3, 2013
Product type
Drugs
Recall number
D-225-2013
Classification
Class II
Recalling firm
CareFusion 213, LLC
Product quantity
3,032,000 applicators
Termination date
May 12, 2014
Reason for recall
Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.
Voluntary / mandated
Voluntary: Firm initiated
Product description
SEPP 2% Iodine Tincture USP (47% v/v Ethyl Alcohol, 2% w/v Iodine, USP, Sodium Iodide USP, & Purified Water USP), packaged in a) 200-count applicators (Net 0.67 mL each) per carton, Cat. No 260261, NDC 54365-161-01, CareFusion, Leawood, KS 66211; b) 3000-count applicators (Net 0.67 mL each) per case, Cat. No 260431, NDC 54365-151-01, CareFusion, Leawood, KS 66211; and c) 3000-count applicators (Net 0.67 mL each) per case, Reorder TA6200, Manufactured for: Tri-State Hospital Supply Corporation, Howell, MI 48843.
Distribution pattern
Nationwide, Puerto Rico, Virgin Islands, Malaysia, and United Kingdom
Recall initiation date
Mar 4, 2013
Initial firm notification
Letter
Center classification date
Mar 28, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-225-2013, published Apr 3, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls